- $0.76m
- $7.70m
- $73.57m
- 46
- 87
- 22
- 51
Annual income statement for Omniq, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 55.2 | 78.3 | 103 | 81.2 | 73.6 |
| Cost of Revenue | |||||
| Gross Profit | 10.9 | 16.7 | 22.1 | 15.7 | 15.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 64.2 | 88.7 | 112 | 107 | 80.5 |
| Operating Profit | -8.98 | -10.5 | -9.55 | -26.2 | -6.91 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11.5 | -13 | -13.6 | -30.1 | -10.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.5 | -13.1 | -13.6 | -29.4 | -10 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.5 | -13.4 | -13.7 | -29.4 | -10 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.3 | -13.4 | -13.9 | -29.5 | -10 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.62 | -2.21 | -1.83 | -2.37 | -0.938 |